Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients

Biomedicine and Pharmacotherapy

Volumn 59, Issue 10, 2005, Pages 541-544

  Galetta, Fabio ^a   Franzoni, Ferdinando ^a   Cervetti, Giulia ^a   Cecconi, Nadia ^a   Carpi, Angelo ^a   Petrini, Mario ^a   Santoro, Gino ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Anthracycline; Dexrazoxane; Epirubicin; Lymphoma; QT dispersion

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; CYTARABINE; EPIRUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; RAZOXANE; VINCRISTINE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART RATE; HUMAN; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; STATISTICAL SIGNIFICANCE;

ANTIBIOTICS, ANTINEOPLASTIC; ARRHYTHMIA; CARDIOVASCULAR AGENTS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; EPIRUBICIN; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; RAZOXANE; TIME FACTORS;

EID: 29244472088     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2004.12.003     Document Type: Article

References (29)

1. L. Lenaz, and J. Page Cardiotoxicity of adriamycin and related anthracyclines Cancer Treat. Rev. 3 1976 11 120
2. T. Nousiainen, E. Vanninen, A. Rantala, E. Jantunen, and J. Hartikainen QT dispersion and late potentials doxorubicin therapy for non-Hodgkin's lynphoma JIM 245 1999 359 364
3. M. Pye, A.C. Quinn, and S.M. Cobbe QT interval dispersion: a non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias? Br. Heart J. 71 1994 511 514
4. G.S. Fu, A. Meissner, and R. Simon Repolarization dispersion and sudden death in patients with impaired left ventricular function Eur. Heart J. 18 1997 281 289
5. S. Balanescu, M. Galinier, J. Fourcade, M. Dorobantu, J.P. Albenque, P. Massabuau, J.M. Fauvel, and J.P. Bounhoure Correlation between QT interval dispersion and ventricular arrhythmia in hypertension Arch. Mal. Coeur Vaiss 89 1996 987 990
6. G. Buja, M. Miorelli, P. Turrini, P. Melacini, and A. Nava Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death Am. J. Cardiol. 72 1993 973 976
7. H. Shimizu, Y. Ohnishi, T. Inoue, and M. Yokoyama J QT and JT dispersion in patients with monomorphic or polymorphic ventricular tachycardia/ventricular fibrillation Electrocardiol 34 2001 119 125
8. V.B. Pai, and M.C. Nahata Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention Drug Saf. 22 2000 263 302
9. K. Hellmann Overview and historical development of dexrazoxane Sem Oncol. 25 Suppl 10 1998 48 54
10. M.M. Oken, R.H. Creech, D.C. Tormey, J. Horton, T.E. Davis, and E.T. McFadden Toxicity and response criteria of the Eastern Cooperative Oncology Group Am. J. Clin. Oncol. 5 6 1982 649 655
11. A. Cupisti, F. Galetta, R. Caprioli, E. Morelli, G.C. Tintori, and F. Franzoni Potassium removal increases the QTc interval dispersion during hemodialysis Nephron 82 2 1999 122 126
12. F. Galetta, F. Franzoni, A. Cupisti, D. Belliti, F. Prattichizzo, and M. Rolla QT interval dispersion in young women with anorexia nervosa J. Pediatr. 140 4 2002 456 460
13. M.C. de Bruyne, A.W. Hoes, J.A. Kors, A. Hofman, J.H. van Bemmel, and D.E. Grobbee Prolonged QT interval predicts cardiac and all-cause mortality in the elderly. The Rotterdam Study Eur. Heart J. 20 1999 278 284
14. P. Kulakowski, S. Karczmarewicz, A. Czepiel, E. Makowska, M. Soszynska, and L. Ceremuzynski QT interval dispersion in ventricular beats: a non-invasive marker of susceptibility to sustained ventricular arrhythmias Pacing Clin. Electrophysiol. 24 2001 352 357
15. K.J.M. Schimmel, D.J. Richel, R.B.A. van den Brink, and H.J. Guchelaar Cardiotoxicity of cytotoxic drugs Cancer Treat. Rev. 30 2004 181 191
16. B.B. Hasinoff, K. Hellmann, E.H. Hermann, and V.J. Ferrans Chemical, biological, and clinical aspects of dexrazoxane and other bisdioxopiperazines Curr. Med. Chem. 5 1998 1 28
17. Y.A. Kuryshev, G.M. Brittenham, H. Fujioka, P. Kannan, C.C. Shieh, and S.A. Cohen Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes. Implications for the arrhythmogenesis of human siderotic heart disease Circulation 100 1999 675 683
18. P. Venditti, M. Balestrieri, T. De Leo, and S. Di Meo Free radical involvement in doxorubicin-induced electrophysiological alterations in rat papillary muscle fibres Cardiovasc. Res. 38 1998 695 702
19. T. Li, I. Danelisen, A. Bellò-Klein, and P.K. Singal Effects of probucol on changes of antioxidant enzymes in adriamycin-induced cardiomyopathy in rats Cardiovasc. Res. 46 2000 523 530
20. E. Cerbai, G. Ambrosio, F. Porciatti, M. Chiariello, A. Giotti, and A. Mugelli Cellular electrophysiological basis for oxygen radical-induced arrhythmias. A patch-clamp study in guinea pig ventricular myocytes Circulation 84 1991 1773 1782
21. H. Nakaya, N. Tohse, and M. Kanno Electrophysiological derangements induced by lipid peroxidation in cardiac tissue Am. J. Physiol. 253 1987 H1089 H1097
22. V.J. Ferrans Overview of cardiac pathology in relation to anthracycline cardiotoxicity Cancer Treat. Rep. 62 1978 955 961
23. J.H. Doroshow Effect of anthracycline antibiotics on oxygen radical formation in rat heart Cancer Res. 43 1983 460 472
24. M.T. Tarr, and D.P. Valenzeno Modification of cardiac action potential by photosensitizer generated reactive oxygen J. Mol. Cell. Cardiol. 21 1989 539 543
25. G. Yjeerdsma, M.T. Meinardi, van De Graff, N.P. van Den Berg, N.H. Mulder, and H.J. Crijns Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables Heart 82 4 1999 419 423
26. J.A. Abildskov Adrenergic effects of the QT interval on the electrocardiogram Am. Heart J. 92 1976 210 216
27. R.L. Basser, M.M. Sobol, G. Duggan, J. Cebon, M.A. Rosenthal, G. Mihaly, and M.D. Green Comparative study of pharmacokinetics and toxicity of the high-dose epirubicin with or without dexrazoxane in patients with advanced malignancy J. Clin. Oncol. 12 1994 1659 1666
28. A. Murray, N.B. McLaughlin, and R.W. Campbell Measuring QT dispersion: man versus machine Heart 77 1997 539 542
29. H.T. Tran, C. Fan, W.Q. Tu, H. Kertland, J. Kluger, and M.S.S. Chow QT measurement, a comparison of three simple methods Ann Noninvasive Electrocardiol 3 1998 228 231